CID 470710

Bdbm2060

Structural Information

Molecular Formula
C20H17ClN8OS
SMILES
CCN1C2=C(C=CC(=N2)Cl)N(C(=O)C3=C1N=CC(=C3)CSC4=NC=NC5=C4C=NN5)C
InChI
InChI=1S/C20H17ClN8OS/c1-3-29-17-12(20(30)28(2)14-4-5-15(21)26-18(14)29)6-11(7-22-17)9-31-19-13-8-25-27-16(13)23-10-24-19/h4-8,10H,3,9H2,1-2H3,(H,23,24,25,27)
InChIKey
HHTVAFPSLHBBQG-UHFFFAOYSA-N
Compound name
5-chloro-2-ethyl-9-methyl-13-(1H-pyrazolo[3,4-d]pyrimidin-4-ylsulfanylmethyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

1
Patents

452.09344 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 453.10072 207.8
[M+Na]+ 475.08266 223.1
[M-H]- 451.08616 209.0
[M+NH4]+ 470.12726 212.6
[M+K]+ 491.05660 216.6
[M+H-H2O]+ 435.09070 194.5
[M+HCOO]- 497.09164 209.8
[M+CH3COO]- 511.10729 214.7
[M+Na-2H]- 473.06811 208.9
[M]+ 452.09289 212.2
[M]- 452.09399 212.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.